List of Tables
Table 1. Global Implantable Drug Eluting Stent Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Implantable Drug Eluting Stent Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Implantable Drug Eluting Stent Market Competitive Situation by Manufacturers in 2025
Table 4. Global Implantable Drug Eluting Stent Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Implantable Drug Eluting Stent Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Implantable Drug Eluting Stent Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Implantable Drug Eluting Stent Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Implantable Drug Eluting Stent Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Implantable Drug Eluting Stent, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Implantable Drug Eluting Stent, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Implantable Drug Eluting Stent, Product Types and Applications
Table 12. Global Key Manufacturers of Implantable Drug Eluting Stent, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Implantable Drug Eluting Stent Companies by Tier (Tier 1, Tier 2, Tier 3), based on Implantable Drug Eluting Stent Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Implantable Drug Eluting Stent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Implantable Drug Eluting Stent Sales by Region (K Units), 2021–2026
Table 18. Global Implantable Drug Eluting Stent Sales Market Share by Region (2021–2026)
Table 19. Global Implantable Drug Eluting Stent Sales by Region (K Units), 2027–2032
Table 20. Global Implantable Drug Eluting Stent Sales Market Share by Region (2027–2032)
Table 21. Global Implantable Drug Eluting Stent Revenue by Region (US$ Million), 2021–2026
Table 22. Global Implantable Drug Eluting Stent Revenue Market Share by Region (2021–2026)
Table 23. Global Implantable Drug Eluting Stent Revenue by Region (US$ Million), 2027–2032
Table 24. Global Implantable Drug Eluting Stent Revenue Market Share by Region (2027–2032)
Table 25. North America Implantable Drug Eluting Stent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Implantable Drug Eluting Stent Sales by Country (K Units), 2021–2026
Table 27. North America Implantable Drug Eluting Stent Sales by Country (K Units), 2027–2032
Table 28. North America Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2021–2026
Table 29. North America Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Implantable Drug Eluting Stent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Implantable Drug Eluting Stent Sales by Country (K Units), 2021–2026
Table 32. Europe Implantable Drug Eluting Stent Sales by Country (K Units), 2027–2032
Table 33. Europe Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Implantable Drug Eluting Stent Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Implantable Drug Eluting Stent Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Implantable Drug Eluting Stent Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Implantable Drug Eluting Stent Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Implantable Drug Eluting Stent Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Implantable Drug Eluting Stent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Implantable Drug Eluting Stent Sales by Country (K Units), 2021–2026
Table 42. Latin America Implantable Drug Eluting Stent Sales by Country (K Units), 2027–2032
Table 43. Latin America Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Implantable Drug Eluting Stent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Implantable Drug Eluting Stent Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Implantable Drug Eluting Stent Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Implantable Drug Eluting Stent Revenue by Country (US$ Million), 2027–2032
Table 50. Global Implantable Drug Eluting Stent Sales (K Units) by Type (2021–2026)
Table 51. Global Implantable Drug Eluting Stent Sales (K Units) by Type (2027–2032)
Table 52. Global Implantable Drug Eluting Stent Sales Market Share by Type (2021–2026)
Table 53. Global Implantable Drug Eluting Stent Sales Market Share by Type (2027–2032)
Table 54. Global Implantable Drug Eluting Stent Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Implantable Drug Eluting Stent Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2021–2026)
Table 57. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2027–2032)
Table 58. Global Implantable Drug Eluting Stent Price (US$/Unit) by Type (2021–2026)
Table 59. Global Implantable Drug Eluting Stent Price (US$/Unit) by Type (2027–2032)
Table 60. Global Implantable Drug Eluting Stent Sales (K Units) by Application (2021–2026)
Table 61. Global Implantable Drug Eluting Stent Sales (K Units) by Application (2027–2032)
Table 62. Global Implantable Drug Eluting Stent Sales Market Share by Application (2021–2026)
Table 63. Global Implantable Drug Eluting Stent Sales Market Share by Application (2027–2032)
Table 64. Global Implantable Drug Eluting Stent Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Implantable Drug Eluting Stent Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2021–2026)
Table 67. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2027–2032)
Table 68. Global Implantable Drug Eluting Stent Price (US$/Unit) by Application (2021–2026)
Table 69. Global Implantable Drug Eluting Stent Price (US$/Unit) by Application (2027–2032)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Abbott Implantable Drug Eluting Stent Product
Table 74. Abbott Recent Developments/Updates
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Medtronic Implantable Drug Eluting Stent Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Boston Scientific Company Information
Table 81. Boston Scientific Description and Business Overview
Table 82. Boston Scientific Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Boston Scientific Implantable Drug Eluting Stent Product
Table 84. Boston Scientific Recent Developments/Updates
Table 85. Lepu Medical Company Information
Table 86. Lepu Medical Description and Business Overview
Table 87. Lepu Medical Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Lepu Medical Implantable Drug Eluting Stent Product
Table 89. Lepu Medical Recent Developments/Updates
Table 90. Microport Medical Company Information
Table 91. Microport Medical Description and Business Overview
Table 92. Microport Medical Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Microport Medical Implantable Drug Eluting Stent Product
Table 94. Microport Medical Recent Developments/Updates
Table 95. SINOMED Company Information
Table 96. SINOMED Description and Business Overview
Table 97. SINOMED Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. SINOMED Implantable Drug Eluting Stent Product
Table 99. SINOMED Recent Developments/Updates
Table 100. Yinyi Biotech Company Information
Table 101. Yinyi Biotech Description and Business Overview
Table 102. Yinyi Biotech Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Yinyi Biotech Implantable Drug Eluting Stent Product
Table 104. Yinyi Biotech Recent Developments/Updates
Table 105. Beijing Amsino Medical Company Information
Table 106. Beijing Amsino Medical Description and Business Overview
Table 107. Beijing Amsino Medical Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Beijing Amsino Medical Implantable Drug Eluting Stent Product
Table 109. Beijing Amsino Medical Recent Developments/Updates
Table 110. Terumo Company Information
Table 111. Terumo Description and Business Overview
Table 112. Terumo Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Terumo Implantable Drug Eluting Stent Product
Table 114. Terumo Recent Developments/Updates
Table 115. Drug-eluting Stent Company Information
Table 116. Drug-eluting Stent Description and Business Overview
Table 117. Drug-eluting Stent Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Drug-eluting Stent Implantable Drug Eluting Stent Product
Table 119. Drug-eluting Stent Recent Developments/Updates
Table 120. Cook Company Information
Table 121. Cook Description and Business Overview
Table 122. Cook Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Cook Implantable Drug Eluting Stent Product
Table 124. Cook Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Implantable Drug Eluting Stent Distributors List
Table 128. Implantable Drug Eluting Stent Customers List
Table 129. Implantable Drug Eluting Stent Market Trends
Table 130. Implantable Drug Eluting Stent Market Drivers
Table 131. Implantable Drug Eluting Stent Market Challenges
Table 132. Implantable Drug Eluting Stent Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Implantable Drug Eluting Stent
Figure 2. Global Implantable Drug Eluting Stent Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Implantable Drug Eluting Stent Market Share by Type: 2025 & 2032
Figure 4. Rapamycin Product Picture
Figure 5. Paclitaxel Product Picture
Figure 6. Everolimus Product Picture
Figure 7. Other Product Picture
Figure 8. Global Implantable Drug Eluting Stent Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Implantable Drug Eluting Stent Market Share by Application: 2025 & 2032
Figure 10. Coronary
Figure 11. Peripheral Vascular
Figure 12. Others
Figure 13. Global Implantable Drug Eluting Stent Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Implantable Drug Eluting Stent Market Size (US$ Million), 2021–2032
Figure 15. Global Implantable Drug Eluting Stent Sales (K Units), 2021–2032
Figure 16. Global Implantable Drug Eluting Stent Average Price (US$/Unit), 2021–2032
Figure 17. Implantable Drug Eluting Stent Report Years Considered
Figure 18. Implantable Drug Eluting Stent Sales Share by Manufacturers in 2025
Figure 19. Global Implantable Drug Eluting Stent Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Implantable Drug Eluting Stent Players: Market Share by Revenue in Implantable Drug Eluting Stent in 2025
Figure 21. Implantable Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Implantable Drug Eluting Stent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Implantable Drug Eluting Stent Sales Market Share by Country (2021–2032)
Figure 24. North America Implantable Drug Eluting Stent Revenue Market Share by Country (2021–2032)
Figure 25. United States Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Implantable Drug Eluting Stent Sales Market Share by Country (2021–2032)
Figure 28. Europe Implantable Drug Eluting Stent Revenue Market Share by Country (2021–2032)
Figure 29. Germany Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Implantable Drug Eluting Stent Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Implantable Drug Eluting Stent Revenue Market Share by Region (2021–2032)
Figure 36. China Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Implantable Drug Eluting Stent Sales Market Share by Country (2021–2032)
Figure 44. Latin America Implantable Drug Eluting Stent Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Implantable Drug Eluting Stent Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Implantable Drug Eluting Stent Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Implantable Drug Eluting Stent Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Implantable Drug Eluting Stent by Type (2021–2032)
Figure 55. Global Revenue Market Share of Implantable Drug Eluting Stent by Type (2021–2032)
Figure 56. Global Implantable Drug Eluting Stent Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Implantable Drug Eluting Stent by Application (2021–2032)
Figure 58. Global Revenue Market Share of Implantable Drug Eluting Stent by Application (2021–2032)
Figure 59. Global Implantable Drug Eluting Stent Price (US$/Unit) by Application (2021–2032)
Figure 60. Implantable Drug Eluting Stent Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
